Athira Pharma Inc (ATHA) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.30x
Athira Pharma Inc (ATHA) has a Cash Flow-to-Debt Ratio of -0.30x as of December 2025, meaning its operating cash flow of $-19.40 Million could theoretically repay 0% of its total liabilities ($64.36 Million) in one year. See financial agility of Athira Pharma Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.30x
Operating CF / Total Liabilities
Operating Cash Flow
$-19.40 Million
USD
Total Liabilities
$64.36 Million
USD
Data as of
Dec 2025
Most recent filing
Athira Pharma Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Athira Pharma Inc across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Athira Pharma Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Athira Pharma Inc (2018–2025)
Year-by-year debt coverage analysis for Athira Pharma Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.71x | $-45.73 Million | $64.36 Million | ▲ +89.8% |
| 2024 | -6.97x | $-97.17 Million | $13.94 Million | ▼ -108.0% |
| 2023 | -3.35x | $-100.75 Million | $30.06 Million | ▼ -6.5% |
| 2022 | -3.15x | $-72.47 Million | $23.02 Million | ▲ +20.2% |
| 2021 | -3.95x | $-43.10 Million | $10.92 Million | ▲ +13.6% |
| 2020 | -4.57x | $-24.11 Million | $5.28 Million | ▼ -2594.6% |
| 2019 | -0.17x | $-3.71 Million | $21.91 Million | ▲ +25.1% |
| 2018 | -0.23x | $-4.48 Million | $19.82 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.